Thoracic Cancer
Scope & Guideline
Unlocking breakthroughs in thoracic malignancies.
Introduction
Aims and Scopes
- Lung Cancer Research:
The journal publishes extensive research on various subtypes of lung cancer, emphasizing molecular mechanisms, genetic alterations, and therapeutic strategies. - Clinical Trials and Treatment Protocols:
It features studies on clinical trials, treatment protocols, and real-world data that inform the management of lung and thoracic cancers, including novel therapies and combination treatments. - Biomarkers and Prognostic Factors:
Research on the identification and validation of biomarkers for diagnosis, prognosis, and treatment response in lung cancer patients is a key focus. - Surgical Techniques and Innovations:
The journal highlights advancements in surgical techniques, including minimally invasive approaches and robotic-assisted surgeries for lung cancer and other thoracic malignancies. - Immunotherapy and Targeted Therapies:
It covers the ongoing research on immunotherapy and targeted therapies, including their mechanisms, efficacy, and associated adverse effects. - Epidemiology and Health Outcomes:
The journal addresses epidemiological studies that explore the incidence, risk factors, and outcomes related to thoracic cancers, contributing to public health knowledge.
Trending and Emerging
- Genomic and Molecular Profiling:
There is a growing emphasis on genomic and molecular profiling of thoracic cancers, which aids in personalized medicine approaches and targeted therapies. - Liquid Biopsy and Non-invasive Diagnostics:
Research focusing on liquid biopsy techniques for early detection and monitoring of lung cancer is on the rise, offering less invasive options for patient management. - Immunotherapy Combinations:
Studies exploring combinations of immunotherapy with other treatment modalities, including chemotherapy and targeted therapies, are increasingly prevalent, indicating a shift towards multifaceted treatment strategies. - Artificial Intelligence and Machine Learning:
The integration of artificial intelligence and machine learning in diagnostic processes and treatment planning is emerging as a significant trend, reflecting advancements in technology within oncology. - Patient-Centered Outcomes and Quality of Life:
Research focusing on patient-reported outcomes, quality of life, and survivorship issues in lung cancer patients is gaining prominence, highlighting the importance of holistic care.
Declining or Waning
- Traditional Chemotherapy Studies:
There has been a noticeable decrease in publications focused solely on traditional chemotherapy regimens, as the field shifts towards exploring immunotherapies and targeted therapies. - Basic Science without Clinical Application:
Research that does not bridge basic science findings with clinical applications appears to be declining, suggesting a preference for studies that translate laboratory results into clinical practice. - Single-Institution Studies:
The journal has moved towards multicenter studies and collaborative research, leading to fewer publications from single-institution experiences, which may limit the diversity of reported outcomes. - Radiation Therapy Alone:
Research focused exclusively on radiation therapy without the integration of immunotherapy or targeted agents has diminished, as combined modalities are increasingly favored. - Case Reports with Limited Generalizability:
The number of case reports, particularly those that do not provide broader insights applicable to larger patient populations, seems to be waning as the journal emphasizes more comprehensive studies.
Similar Journals
JOURNAL OF THORACIC IMAGING
Transforming Thoracic Medicine through Research ExcellenceThe JOURNAL OF THORACIC IMAGING, published by Lippincott Williams & Wilkins, stands as a pivotal resource in the fields of Pulmonary and Respiratory Medicine as well as Radiology, Nuclear Medicine, and Imaging. With the ISSN 0883-5993 and E-ISSN 1536-0237, this esteemed journal has been providing critical insights and advancements since its inception in 1985, contributing significantly to the ongoing dialogue and research within these disciplines. The journal maintains a commendable position, ranking in the Q2 category in both relevant fields and achieving an impressive Scopus ranking of #46 out of 333 in Radiology and #30 out of 155 in Pulmonary Medicine, showcasing its influence and impact (with particles in the 86th and 80th percentiles, respectively). While the journal is not open access, it continues to disseminate high-quality research that informs clinical best practices and emerging technologies in thoracic imaging. As a leading publication, it serves as an essential tool for researchers, clinicians, and students seeking to stay at the forefront of thoracic health innovations.
Kardiochirurgia i Torakochirurgia Polska-Polish Journal of Thoracic and Cardiovascular Surgery
Transforming Patient Outcomes with Cutting-edge InsightsKardiochirurgia i Torakochirurgia Polska - Polish Journal of Thoracic and Cardiovascular Surgery is an esteemed Open Access journal dedicated to the vibrant fields of thoracic and cardiovascular surgery. Established by TERMEDIA PUBLISHING HOUSE LTD in Poland, this journal has been providing a platform for innovative research and clinical practices since its inception. The journal, indexed with ISSN 1731-5530 and E-ISSN 1897-4252, plays a crucial role in disseminating knowledge within its domain, promoting advancements that impact patient care and outcomes. With a history of publication covering from 2008 to 2024, it features high-quality articles with contemporary insights in surgery and cardiology, ranked in Q4 and Q3 categories respectively as of 2023. With its presence in Scopus, where it holds notable ranks in both the surgery and cardiology disciplines, this journal is committed to fostering collaboration and innovation among researchers, professionals, and aspiring students alike, making it an indispensable resource for those engaged in the intricacies of thoracic and cardiovascular surgery.
Molecular and Clinical Oncology
Uncovering the molecular secrets of oncology.Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.
Clinical Lung Cancer
Empowering clinicians with cutting-edge lung cancer studies.Clinical Lung Cancer is a prestigious journal published by CIG MEDIA GROUP, LP, dedicated to advancing the field of oncology and pulmonary medicine since its establishment in 2000. With an impressive impact factor and high ranking within its fields—achieving Q1 status in Oncology and Pulmonary and Respiratory Medicine in 2023—this journal serves as a vital resource for researchers, clinicians, and students alike. Covering a wide scope of topics related to lung cancer, Clinical Lung Cancer offers a platform for innovative studies, clinical trials, and comprehensive reviews that contribute to both theory and practice. While it operates on a subscription basis, the quality of content is reflected in its ranked status within the top quartile of cancer research journals. This journal plays a critical role in shaping the future of lung cancer research and treatment, making it an essential destination for those looking to stay at the forefront of the field.
Thoracic and Cardiovascular Surgeon Reports
Advancing surgical excellence in thoracic and cardiovascular care.Thoracic and Cardiovascular Surgeon Reports is a pivotal academic journal dedicated to the dissemination of innovative research and clinical practices in the fields of thoracic and cardiovascular surgery. Published by GEORG THIEME VERLAG KG, this journal has been an open-access publication since 2013, fostering a broader reach and enhancing visibility for authors and researchers globally. With its commitment to high-quality peer-reviewed articles, Thoracic and Cardiovascular Surgeon Reports serves as an essential platform for surgeons, clinicians, and scholars to share findings that advance medical knowledge, improve patient outcomes, and refine surgical techniques. The journal aims to bridge the gap between research and practical application, catering to an audience keen on staying updated with the latest in thoracic and cardiovascular interventions, making it a valuable resource in an ever-evolving medical landscape.
Thoracic Surgery Clinics
Bridging Research and Practice in Thoracic Surgery.Thoracic Surgery Clinics is a premier academic journal dedicated to advancing the field of thoracic surgery and related disciplines. Published by W B Saunders Co-Elsevier Inc, this journal has been a vital resource since its inception in 2004, presenting high-quality peer-reviewed articles that embrace the latest research, practice innovations, and clinical guidelines impacting thoracic and respiratory health. With a strong focus on multidisciplinary approaches, it caters to a diverse audience of researchers, medical professionals, and students. The journal currently ranks impressively in the Q2 category within Medicine (miscellaneous), Pulmonary and Respiratory Medicine, and Surgery, indicating its substantial influence and reach in the medical community. While not available as an open access publication, its concentrated aim is to enhance the knowledge base and clinical skills necessary for tackling complex thoracic surgical challenges. Join the ongoing discourse in this dynamic field through Thoracic Surgery Clinics, where cutting-edge research meets practical application.
Clinical Lymphoma Myeloma & Leukemia
Pioneering Insights into Lymphoma, Myeloma, and LeukemiaClinical Lymphoma Myeloma & Leukemia is a prestigious journal dedicated to the study and treatment of hematologic malignancies, offering a vital platform for researchers and healthcare professionals in the fields of oncology, hematology, and cancer research. Published by CIG MEDIA GROUP, LP, this journal has established itself as a crucial resource since its inception in 2010, with a continuous commitment to disseminating knowledge until at least 2024. With an impact factor that objectively reflects its influence, it is rated in Q3 quartiles in both Cancer Research and Hematology as well as in Oncology as of 2023. Researchers can access a wealth of articles and studies that explore various dimensions of lymphoma, myeloma, and leukemia, thus fostering an environment of collaboration and innovation. Although it currently does not offer full open access, its extensive archive and rigorous peer-review process ensure the publication of high-quality research, making it an essential resource for anyone dedicated to advancing the science and practice of treating blood cancers.
Indian Journal of Thoracic and Cardiovascular Surgery
Exploring Innovations in Cardiac and Pulmonary SurgeryIndian Journal of Thoracic and Cardiovascular Surgery, published by SPRINGER INDIA, serves as a vital platform for the dissemination of innovative research and clinical advancements in the fields of cardiology, cardiovascular medicine, pulmonary, and respiratory medicine. With a rich history dating back to 1982 and spanning multiple years through to 2024, this journal aims to provide a comprehensive view of both theoretical and practical aspects of thoracic and cardiovascular surgery. Although it currently holds a Q3 quartile ranking across various relevant categories, researchers and practitioners can benefit from its insightful articles that contribute to ongoing discussions and advancements in these critical medical areas. The journal does not offer open access presently, yet it is accessible through major academic databases, providing valuable resources for professionals and students keen on enhancing their understanding and expertise. In a rapidly evolving field marked by technological advancements and novel research, the Indian Journal of Thoracic and Cardiovascular Surgery remains integral to fostering collaboration and education among its audience.
Thoracic Research and Practice
Empowering Respiratory Medicine with Open Access InsightsThoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.
Clinical Genitourinary Cancer
Exploring breakthroughs in cancer treatment and management.Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.